Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.907 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.907 |
High Similarity |
NPD1613 |
Approved |
0.8906 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8837 |
High Similarity |
NPD3027 |
Phase 3 |
0.8828 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD3018 |
Phase 2 |
0.8473 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8438 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.8374 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.8372 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8372 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8359 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8346 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8189 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.812 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8041 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7955 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7939 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7929 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7867 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7815 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7801 |
Intermediate Similarity |
NPD2796 |
Approved |
0.78 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7762 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7669 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7664 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD4538 |
Approved |
0.766 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7658 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7639 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7616 |
Intermediate Similarity |
NPD37 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.76 |
Intermediate Similarity |
NPD4678 |
Approved |
0.76 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7578 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7538 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD228 |
Approved |
0.75 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7484 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7483 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD290 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7438 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD3537 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7388 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7383 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7375 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7362 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7338 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6799 |
Approved |
0.731 |
Intermediate Similarity |
NPD6099 |
Approved |
0.731 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7303 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7296 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2557 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7273 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7261 |
Intermediate Similarity |
NPD919 |
Approved |
0.726 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD3530 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD3532 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3531 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6580 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7206 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7192 |
Intermediate Similarity |
NPD6032 |
Approved |
0.719 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7185 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7185 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7185 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7185 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7185 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7185 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7179 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD5976 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3384 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7153 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152
|
Intermediate Similarity |
NPD1424 |
Approved |